# FDA Inspection 1038849 - Statline - January 24, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/statline/f0ce8126-c73c-41d3-9f45-35e403a1061c
Source feed: FDA_Inspections

> FDA Inspection 1038849 for Statline on January 24, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1038849
- Company Name: Statline
- Inspection Date: 2018-01-24
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1038849 - 2018-01-24](https://www.globalkeysolutions.net/records/fda_inspections/statline/39d1ecdc-07c2-45b1-8cf8-9e0311853882)
- [FDA Inspection 815288 - 2013-01-17](https://www.globalkeysolutions.net/records/fda_inspections/statline/15b708fc-4e15-4fad-8703-0ff140b46302)
- [FDA Inspection 757123 - 2011-12-14](https://www.globalkeysolutions.net/records/fda_inspections/statline/be7afca1-16f7-49e6-8a66-c9fcf634ef6a)
- [FDA Inspection 666879 - 2010-06-11](https://www.globalkeysolutions.net/records/fda_inspections/statline/2951deb1-255b-463d-962d-bf6238cc8313)

Company: https://www.globalkeysolutions.net/companies/statline/d574ce59-e67c-4b1c-92b0-6b9fc15d3772

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d